Elite Pharmaceuticals Inc
OTCQB:ELTP

  • LAST PRICE
    0.6177
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.6177
  • Day Range
    ---
  • 52 Week Range
    0.1213
    0.7549
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Pharmaceuticals - Generic & Specialty Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ELTP
Elite Pharmaceuticals Inc
659.9M
-105.6x
---
CRMD
CorMedix Inc
626.8M
-12.9x
---
ZVRA
Zevra Therapeutics Inc
487.3M
-4.7x
---
ETON
Eton Pharmaceuticals Inc
277.7M
-50.4x
---
SCLX
Scilex Holding Co
105.8M
-0.4x
---
CPLFY
Cipla Ltd
14.0B
0.0x
---
As of 2024-11-22

Company Information

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets, Loxapine Succinate 5mg, 10mg, 25mg and 50gm capsules, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Dantrolene Sodium Capsules 25mg, 50mg and 100mg, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.

Contact Information

Headquarters
165 Ludlow AveNORTHVALE, NJ, United States 07647-2305
Phone
201-750-2646
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer
Nasrat Hakim
Chief Financial Officer, Treasurer, Company Secretary
Carter Ward
Executive Vice President - Operations
Douglas Plassche
Chief Commercial Officer
Kirko Kirkov
Independent Director
Davis Caskey

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$659.9M
Revenue (TTM)
$71.2M
Shares Outstanding
1.1B
Elite Pharmaceuticals Inc does not pay a dividend.
Beta
0.22
EPS
$-0.01
Book Value
$0.05
P/E Ratio
-105.6x
Price/Sales (TTM)
9.3
Price/Cash Flow (TTM)
---
Operating Margin
23.00%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.